When does this change take effect?

This change is effective Jan 1, 2026.

Medicare AdvantageCoverageMedium impact

MA05.071, Remote Electrical Neuromodulation for Migraines

Q: Who is affected by this change?

This affects Independence Blue Cross Neurology, Pain Management, Family Medicine, Internal Medicine providers on Medicare Advantage plans.

Independence Blue Cross·Neurology, Pain Management, Family Medicine +1 more·Medical Policy

Effective date

Jan 1, 2026

We identified it

Jun 19, 2026

Days to comply

—

Summary

A new Medicare Advantage policy MA05.071 for Remote Electrical Neuromodulation for Migraines has been established, effective January 1, 2026. This policy will likely establish coverage criteria and billing guidelines for remote electrical neuromodulation devices used to treat migraines.

Action Required

Action needed

Before January 1, 2026: Billing team must review the full policy MA05.071 at the source URL to understand coverage criteria, prior authorization requirements, and billing guidelines for remote electrical neuromodulation migraine treatments. Update billing system and staff training accordingly once complete policy details are available.

Related policy hubs

Independence Blue Cross policies Neurology Pain Management Family Medicine Internal Medicine